GH Research (GHRS) Share-based Compensation (2021 - 2025)

GH Research (GHRS) recorded quarterly Share-based Compensation of $2.7 million in Q4 2025, up 13.8% quarter-over-quarter from $2.3 million in Q3 2025, and up 249.93% on a YoY basis from $759000.0 in Q4 2024.

GH Research (GHRS) Share-based Compensation (2021 - 2025) Analysis & Trends

GH Research's Share-based Compensation history runs 5 years deep, the most recent figure standing at $2.7 million for Q4 2025.

  • In Q4 2025, Share-based Compensation rose 249.93% year-over-year to $2.7 million; the TTM figure through Dec 2025 stood at $8.5 million (up 626.22% YoY), while the FY2025 annual figure was $13.1 million, up 167.72% from the prior year.
  • Share-based Compensation was $2.7 million for Q4 2025 at GH Research, up from $2.3 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $2.7 million in Q4 2025 to a low of -$138000.0 in Q2 2024.
  • Historically, Share-based Compensation has averaged $779388.9 across 5 years, with a median of $477000.0 in 2022.
  • The sharpest annual moves came in 2024 and 2025: Share-based Compensation tumbled 130.6% in 2024, then soared 1461.59% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $235000.0 in 2021, then jumped by 107.66% to $488000.0 in 2022, then soared by 33.4% to $651000.0 in 2023, then increased by 16.59% to $759000.0 in 2024, then jumped by 249.93% to $2.7 million in 2025.
  • The last three Share-based Compensation figures came in at $2.7 million (Q4 2025), $2.3 million (Q3 2025), and $1.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 305,000.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 166.40 Mn
9 Abivax 94.26 Bn 94.26 Bn - 26.47 Mn
10 GH Research 9.73 Bn 9.63 Bn - 2.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.66 Mn
Dec 31, 2025 2.66 Mn
Sep 30, 2025 2.33 Mn
Sep 30, 2025 2.33 Mn
Jun 30, 2025 1.88 Mn
Jun 30, 2025 1.88 Mn
Mar 31, 2025 1.64 Mn
Mar 31, 2025 1.64 Mn
Dec 31, 2024 759,000.00
Dec 31, 2024 759,000.00
Sep 30, 2024 273,000.00
Sep 30, 2024 273,000.00
Jun 30, 2024 -138,000.00
Jun 30, 2024 -138,000.00
Mar 31, 2024 277,000.00
Mar 31, 2024 277,000.00
Dec 31, 2023 651,000.00
Dec 31, 2023 651,000.00
Sep 30, 2023 647,000.00
Sep 30, 2023 647,000.00